Chemed Corporation CHE
512.16
16.51
3.33%
as of 25 Sep
- Market cap
- $6.5B
- P/E
- 25.7×
Follow CHE
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
24.11% | 25.28% | 25.60% | 27.11% | |
| 16.43% | 16.54% | 15.93% | 16.68% | ||
ROIC |
23.20% | 23.36% | 22.23% | 23.46% | |
Return on Tangible Assets |
90.77% | 119.94% | 161.98% | 152.87% | |
Average Days of Receivables |
31.09 | 26.34 | 30.96 | 26.53 | |
Free Cash Flow per Share |
25.32 | 22.92 | 27.91 | 24.91 | |
Free Cash Flow |
364.45 | 330.05 | 381.71 | 328.12 | |
Capital Expenditures |
(55.20) | (58.23) | (62.04) | (61.84) | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
34.78% | 36.84% | 46.41% | 38.58% | |
Accounts Receivable Turnover |
12.28 | 14.30 | 10.13 | 13.90 | |
Accounts Payable Turnover |
36.51 | 31.43 | 30.30 | 25.60 | |
Inventory Turnover |
187.30 | 216.93 | 229.10 | 206.90 | |
Average Days of Payables |
10.34 | 13.78 | 13.96 | 17.81 | |
Days of Inventory on Hand |
1.77 | 1.61 | 1.53 | 1.60 | |
Tax Rate |
(0.25) | (0.25) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.44% | 16.49% | 16.76% | 16.99% | |
Share Based Compensation of Revenue |
1.52% | 1.48% | 1.44% | 1.46% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.51 | 1.46 | 1.71 | 1.42 | |
Depreciation/Fixed assets |
0.32 | 0.32 | 0.32 | 0.32 | |
Capex/Depreciation |
(0.85) | (0.89) | (0.94) | (0.93) | |
Revenue per Share |
175.81 | 175.72 | 185.78 | 196.98 | |
Operating CF per Share |
29.15 | 26.97 | 32.45 | 29.60 | |
Capex per Share |
(3.84) | (4.04) | (4.54) | (4.69) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
11.02% | 10.48% | 10.23% | 10.60% |
Columns are period end dates